erlotinib hydrochloride has been researched along with eye in 2 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (eye) | Trials (eye) | Recent Studies (post-2010) (eye) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 41,716 | 724 | 8,737 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aritakula, A; Ramasamy, A | 1 |
| Chang, MJ; Choi, HD | 1 |
1 review(s) available for erlotinib hydrochloride and eye
| Article | Year |
|---|---|
Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Digestive System Diseases; Disease-Free Survival; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Eye; Eye Diseases; Female; Gastrointestinal Tract; Humans; Kidney; Kidney Diseases; Lung Neoplasms; Male; Mutation; Protein Kinase Inhibitors | 2020 |
1 other study(ies) available for erlotinib hydrochloride and eye
| Article | Year |
|---|---|
Drosophila-based in vivo assay for the validation of inhibitors of the epidermal growth factor receptor/Ras pathway.
Topics: Animals; Antineoplastic Agents; Biological Assay; Catalytic Domain; Computer Simulation; Drosophila melanogaster; ErbB Receptors; Erlotinib Hydrochloride; Eye; Gefitinib; Gene Expression Regulation; Models, Molecular; Protein Conformation; Protein Structure, Tertiary; Quinazolines; ras Proteins; Wings, Animal | 2008 |